Everest Medicines, a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, announced that the Taiwan Food and Drug Administration has approved the New Drug Application for XERAVA® for the treatment of complicated intra-abdominal infections.
